Quantum
Home > Boards > US Listed > Biotechs >

Histogenics Corporation (HSGX)

HSGX RSS Feed
Add HSGX Price Alert      Hide Sticky   Hide Intro
Moderator: 0210
Search This Board: 
Last Post: 11/16/2018 9:50:01 AM - Followers: 38 - Board type: Free - Posts Today: 3

Histogenics Corporation
830 Winter Street, 3rd Floor
Waltham, MA 02451, United States
Phone: 781-547-7900   Fax: 781-547-4452
Website: http://www.histogenics.com

Histogenics Corporation develops and commercializes regenerative medicine products in the musculoskeletal segment of the marketplace. Its product candidate includes NeoCart, which is in Phase III clinical trials, a first-line therapy for full thickness knee chondral lesions in skeletally mature adults age 18 to 55. The company has an exclusive channel collaboration agreement with Intrexon Corporation for the development and commercialization of allogeneic genetically modified chondrocyte cell therapeutics for the treatment or repair of damaged articular hyaline cartilage in humans. Histogenics Corporation was incorporated in 2000 and is headquartered in Waltham, Massachusetts.
 
Overview
https://www.finviz.com/quote.ashx?t=HSGX
 
Value Proposition, October 5, 2018
http://ir.histogenics.com/static-files/992fecc5-2887-4c36-a2b7-ecfcb113066c
 
Keys  to  HSGX  Profits
1.  More than 85 Global and 45 US-Owned Patents and Licenses + Ability to Survive Credible Patent Challenges:  Robust Intellectual Property covers cell culture, bioreactors and materials.  Provides broad coverage for methods in cartilage production and tissue sciences.   Coverage through 2031.
2.  Strong Real & Strategic Partners:  Take breakthroughs globally with the flip of a switch.  Advanced Regenerative Manufacturing Institute(ARMI)Brigham and Women's Hospital, Cornell University, Harvard UniversityIntrexon, Lonnie Shea, Ph.D., University of MichiganMedinet, Shuichi Mizuno, Ph.D., Dr. R. Lane Smith, Stanford U., Jennifer Elisseeff, Ph.D., Johns Hopkins Medicine, plus others on the Scientific Advisory Board
3.  Leadership:   Management and Board of Directors.
4.  Confident Large Block Owners:  Low Average Turnover Rating.   HSGX $37m mkt cap  [@0.55 pps  x  66.7m O/S   =   $37m].  
5.  HSGX's NeoCart Platform similar to VCEL's MACI restorative cartilage repair product. $710m mkt cap [@16.60 pps  x  42.7m O/S  =  $710m].  VCEL 52-wk high-low $17.51 - $3.63.
Quantum
HSGX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
HSGX News: Quarterly Report (10-q) 11/08/2018 05:26:15 PM
HSGX News: Current Report Filing (8-k) 11/08/2018 07:02:50 AM
HSGX News: Histogenics Corporation Announces Third Quarter 2018 Financial and Operating Results 11/08/2018 06:30:00 AM
HSGX News: Current Report Filing (8-k) 11/01/2018 04:34:52 PM
HSGX News: Histogenics and FDA to Continue Discussions on NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway 11/01/2018 04:05:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#577   Most important step is BLA/FDA approval in the Klinsmann 11/16/18 09:50:01 AM
#576   Phase 3 trial starts sometime in 2019, maybe. https://globenewswire.com/news-re Vector93 11/16/18 08:58:38 AM
#575   Does anyone have any information about HSGX and DesktopDR 11/16/18 08:35:54 AM
#574   Time to squeeze! Lets hope that volume gonna Klinsmann 11/15/18 12:27:30 PM
#573   That would be sick! Let’s do it! Shorts Backstabbed 11/15/18 11:40:39 AM
#572   As stated before - added a bigger chunk Klinsmann 11/15/18 11:37:05 AM
#571   $HSGX - Heavily shorted again yesterday! Back on Backstabbed 11/15/18 09:02:55 AM
#570   $HSGX - I am with ya buddy! Backstabbed 11/15/18 07:12:06 AM
#569   I think (and that´s the most difficult part!) Klinsmann 11/15/18 04:40:48 AM
#568   I hope so also. I did some more DesktopDR 11/14/18 04:40:12 PM
#567   Excellent post! Disquisition 11/14/18 02:23:54 PM
#566   Hopefully so Backstabbed 11/14/18 02:08:11 PM
#565   Great post, gave you a person mark! Klinsmann 11/14/18 02:06:10 PM
#564   Thank you. This information is perfect. This company DesktopDR 11/14/18 01:03:08 PM
#563   So let's start with a brief recap of realfast95 11/14/18 11:24:23 AM
#562   Can someone tell me what the primary endpoint DesktopDR 11/14/18 09:16:17 AM
#561   $HSGX - scratching my head as well as Backstabbed 11/14/18 09:03:16 AM
#560   Can someone tell me what the primary endpoint DesktopDR 11/14/18 08:53:17 AM
#559   $HSGX - Heavily shorted again! Lay off shorts! http://www.nasdaqtrader.com/trade Backstabbed 11/13/18 03:45:18 PM
#558   I am holding, not going any where ;-) Backstabbed 11/12/18 04:15:35 PM
#557   Holding. amaration 11/12/18 04:03:22 PM
#556   Hold. It will bounce. amaration 11/12/18 04:02:52 PM
#555   Is it smart to sell at 52 week Backstabbed 11/12/18 12:12:42 PM
#554   At least intraday about to bottom here - Klinsmann 11/12/18 10:01:36 AM
#553   Nope, not concerned about the wording. They simply Klinsmann 11/12/18 03:32:39 AM
#552   It’s intentionally open language because the FDA has Vector93 11/11/18 09:06:56 AM
#551   Isn't anyone else concerned about the wording in staticmirror79 11/09/18 03:21:13 PM
#550   Showing some decent bounce off .50 . Tozer Max 11/08/18 01:22:38 PM
#549   If .50 doesn’t hold we could see a Tozer Max 11/08/18 11:31:26 AM
#548   I held and bought more. Edmond 11/05/18 07:10:44 PM
#547   $HSGX - people sold for no reason last Backstabbed 11/05/18 10:23:11 AM
#546   HSGX Analysts' Research & Ratings. 0210 11/03/18 11:02:53 PM
#545   HSGX Mgt/BoD own 12.1% or 7.6m shs (this 0210 11/03/18 09:53:41 PM
#544   Split Rock Partners II LP + 150% to 0210 11/03/18 09:25:02 PM
#543   Sio Capital Mgt + 20,500% to 8.1m shs 0210 11/03/18 09:12:12 PM
#542   Perceptive Advisors +280% to 8.4m shs (from 2.2m 0210 11/03/18 09:00:44 PM
#541   Owns 5.3m HSGX shs* (+ 153% from 2.1m 0210 11/03/18 08:39:03 PM
#540   Ride the wave on all Bio stocks Backstabbed 11/02/18 06:42:49 PM
#539   I think you’re right, but when Nov 30 Vector93 11/02/18 06:36:28 PM
#538   $HSGX - today proved how strong most shareholders Backstabbed 11/02/18 05:39:47 PM
#537   Volume was low today, selling was lots of Vector93 11/02/18 05:20:18 PM
#536   $HSGX - added bigly today! Chart is looking Backstabbed 11/02/18 03:13:23 PM
#535   Why are you all of a sudden talking Vector93 11/01/18 07:16:10 PM
#534   Those low .50's were a gift..... DD 11/01/18 07:06:20 PM
#533   Again, the only thing I was pointing out staticmirror79 11/01/18 07:03:10 PM
#532   You just said what I said in my Vector93 11/01/18 06:56:32 PM
#531   Not being pedantic here. That difference in terminology staticmirror79 11/01/18 06:13:17 PM
#530   Of course everyone has been hopeful for quick Klinsmann 11/01/18 05:47:08 PM
#529   It may just do that. Kevin1968 11/01/18 05:45:58 PM
#528   95% discount, same Biotech Platforms: VCEL +0.85 0210 11/01/18 05:34:35 PM
PostSubject